Services for the Production and Stability Testing of Clinical Grade Lentiviral Vector
National Institutes of Health · NIH National Cancer Institute
No listed company matched (Materiality N/A)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N91024Q00183 in this department, oldest first.
- Sep 24, 2024Pre-solicitationOpen
- Dec 2, 2024 · this noticeAward NoticeVECTOR BIOMED INC. · $804K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
Who won similar work
15 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same industry group (NAICS 3254).
| Winner | Awards | Value | Last |
|---|---|---|---|
| CURIA GLOBAL INC | 2 | – + 2 shared | Aug 5, 2026 |
| SRI INTERNATIONAL Menlo Park CA 94025 USA | 2 | – + 2 shared | Jul 8, 2026 |
| ALCHEM LABORATORIES CORPORATION | 2 | – + 2 shared | Aug 5, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $1.7M | Jan 10, 2025 |
| MURTY PHARMACEUTICALS, INC. | 1 | – + 1 shared | Jul 8, 2026 |
| SIA PARTNERS U.S., INC. | 1 | – + 1 shared | Aug 5, 2026 |
| SOUTHWEST RESEARCH INSTITUTE San Antonio TX 78238 USA | 1 | – + 1 shared | Aug 5, 2026 |
| TCG INC | 1 | – + 1 shared | Aug 5, 2026 |
| TCG GREENCHEM INC | 1 | – + 1 shared | Aug 17, 2026 |
| EMINENT SERVICES CORP | 1 | – + 1 shared | Jul 8, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Aug 17, 2026TCG GREENCHEM INC$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026CURIA GLOBAL INC$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026ALCHEM LABORATORIES CORPORATION$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026TCG INC$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026SOUTHWEST RESEARCH INSTITUTE San Antonio TX 78238 USA$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Aug 5, 2026SIA PARTNERS U.S., INC.$49.7M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug SubstancesShared multiple-award ceiling, not one company's win (Materiality N/A)
- Jul 8, 2026EMINENT SERVICES CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug ProductsShared multiple-award ceiling, not one company's win (Materiality N/A)
- Jul 8, 2026KYMANOX CORP$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug ProductsShared multiple-award ceiling, not one company's win (Materiality N/A)
- Jul 8, 2026MURTY PHARMACEUTICALS, INC.$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug ProductsShared multiple-award ceiling, not one company's win (Materiality N/A)
- Jul 8, 2026SRI INTERNATIONAL Menlo Park CA 94025 USA$49.9M (shared ceiling)Chemistry, Manufacturing and Controls and Related Services for Development of Drug ProductsShared multiple-award ceiling, not one company's win (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.